ADPT vs BA · rev $179.0M vs P/E 89, rev $89.46B
Adaptive Biotechnologies Corp (ADPT) versus The Boeing Company (BA) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Latest reported ADPT revenue for 2024-12-31 was $179.0M. Net income was -$159.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. ADPT currently screens at market cap $2.69B.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
ADPT currently screens at market cap $2.69B. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Not investment advice. Open the ADPT and BA stock pages for the full models.
Not investment advice.